Open Access

About the speakers

Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)
15 presentations
0 follower

Professor Peter S Sever

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
4 presentations
1 follower

2 more presentations in this session

PCSK9 inhibitors: the story continues.

Speaker: Professor J. Chapman (Paris, FR)


PCSK9 inhibitors: more volumes to come?

Speaker: Professor J. Chapman (Paris, FR)


Access the full session

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention

Speakers: Professor J. Chapman, Professor P. Sever, Professor J. Chapman, Professor J. Chapman

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb